Google
Trusted Resources: News & Events
Latest announcements and gatherings
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell disease
A Mississippi State University researcher is developing new miniature models to better understand the factors that lead to heart disease and sickle cell anemia.
Renita Horton, assistant professor of agricultural and biological engineering, is using clear polymer “chips” to create cellularized microtissue models, which she then uses to study the mechanisms that lead to cardiovascular related diseases. She hopes this work can aid in improving patient outcomes by identifying novel targets that can be exploited to mitigate some of the organ damage caused by sickle cell disease.
+myBinderRelated Content
-
A randomized controlled trial of home-based computerized working memory training for children with sickle cell disea...Objectives: To determine the effects of...
-
SUSTAIN Clinical Trial Results Show Crizanlizumab Reduced Sickle Cell–Related Pain CrisesResults from the Phase 2 SUSTAIN clinica...
-
Gum Arabic as novel anti-oxidant agent in sickle cell anemia, phase II trialBackground: Sickle cell anemia patien...
-
Sickle Cell & PregnancySickle cell disease often becomes more s...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
When Cracking Down On Opioids Means Tougher Access For Sickle Cell PatientsMany people with sickle cell disease wil...
-
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.